# US 2015/0072344 A1 · Barcoded Universal Marker Indicator (BUMI) Tags

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0072344 A1
- Document ID: US20150072344A1
- Status: Published application
- Kind: A1
- Application number: 14/481,697
- Filed: 2014-09-09
- Published: 2015-03-12
- Earliest claimed: 2013-09-10
- Assignees: Imdaptive Inc.
- Inventors: Steven R. Wiley
- Web page: https://patentgrep.com/patent/US20150072344A1

## CPC

- C12Q 1/6851: Quantitative amplification
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The BUMI tag is an invention which allows different species of mRNAs from different samples to be quantitatively measured at the first strand cDNA generation step, and is not affected by variations in amplification efficiency of different species of molecules, regardless of amplification method. It consists of a blend of defined nucleotides which comprise the bar-coding portion of the tag along with a set of randomly synthesized nucleotides which comprise the UMI (universal marker indicator) portion of the tag. This blend of Barcode and UMI parts comprises the BUMI tag. The two are interspersed so that the fixed nucleotides of the barcode do not form a contiguous region which might cause biases between different barcodes due to undesired complementarity between the barcode and amplification primers/adaptors.

## Claims

### Claim 1

A plurality of polynucleotides each comprising at least one tag polynucleotide, wherein each tag polynucleotide is produced so that its nucleotide sequence consists of a certain number of bases of random sequence and a number m of bases of determined sequence, wherein the maximum number of contigous bases of determined sequence equals m−1.

### Claim 2 (depends on 1)

At least one polynucleotide selected from the plurality of polynucleotides of claim 1.

### Claim 3 (depends on 1)

The plurality of polynucleotides of claim 1 wherein at least one tag polynucleotide is chemically synthesized.

### Claim 4 (depends on 1)

The plurality of polynucleotides of claim 1 wherein, in the nucleotide sequence of the tag polynucleotide, the maximum number of contigous bases of determined sequence is selected from the group consisting of: three; two;
and one.

### Claim 5 (depends on 1)

The plurality of polynucleotides of claim 1 wherein, in the nucleotide sequence of the tag polynucleotide, the number of bases of random sequence plus the number of bases of determined sequence equals a number selected from the group consisting of: (a) a number between 2 and 200; (b) a number between 4 and 100; (c) a number between 6 and 50; (d) a number between 8 and 20; (e) 10; (f) 12; and (g) 15.

### Claim 6 (depends on 5)

The plurality of polynucleotides of claim 5 wherein, in the nucleotide sequence of the tag polynucleotide, the number of bases of random sequence plus the number of bases of determined sequence equals a number between 8 and 20.

### Claim 7 (depends on 1)

The plurality of polynucleotides of claim 1 wherein the nucleotide sequence of at least one tag polynucleotide is GNTNCNCNANTN (SEQ ID NO:1), wherein each ‘N’ can be any base.

### Claim 8 (depends on 1)

A kit comprising the plurality of polynucleotides of claim 1.

### Claim 9 (depends on 6)

A kit comprising the plurality of polynucleotides of claim 6.

### Claim 10

A plurality of polynucleotides produced by a process comprising:
providing a determined nucleotide sequence of length m; producing a plurality of polynucleotides, each comprising a tag polynucleotide having said determined nucleotide sequence interspersed with bases chosen at random from A, C, G, and T or U, such that the maximum number of contiguous bases of said determined nucleotide sequence equals m−1.

### Claim 11 (depends on 10)

At least one polynucleotide selected from the plurality of polynucleotides of claim 10.

### Claim 12 (depends on 10)

The plurality of polynucleotides of claim 10 wherein at least one tag polynucleotide is chemically synthesized.

### Claim 13 (depends on 10)

The plurality of polynucleotides of claim 10 wherein, in the nucleotide sequence of the tag polynucleotide, the maximum number of contigous bases of determined sequence is selected from the group consisting of: three; two; and one.

### Claim 14 (depends on 10)

The plurality of polynucleotides of claim 10 wherein, in the nucleotide sequence of the tag polynucleotide, the number of bases of random sequence plus the number of bases of determined sequence equals a number selected from the group consisting of: (a) a number between 2 and 200; (b) a number between 4 and 100; (c) a number between 6 and 50; (d) a number between 8 and 20; (e) 10; (f) 12; and (g) 15.

### Claim 15 (depends on 14)

The plurality of polynucleotides of claim 14 wherein, in the nucleotide sequence of the tag polynucleotide, the number of bases of random sequence plus the number of bases of determined sequence equals a number between 8 and 20.

### Claim 16 (depends on 10)

The plurality of polynucleotides of claim 10 wherein the nucleotide sequence of at least one tag polynucleotide is GNTNCNCNANTN (SEQ ID NO:1), wherein each ‘N’ can be any base.

### Claim 17 (depends on 10)

A kit comprising the plurality of polynucleotides of claim 10.

### Claim 18

A method for analyzing a sample, the method comprising hybridizing a plurality of polynucleotides to nucleic acid in the sample, wherein each of the plurality of polynucleotides comprises at least one tag polynucleotide, wherein each tag polynucleotide is produced so that its nucleotide sequence consists of a certain number of bases of random sequence and a number m of bases of determined sequence, wherein the maximum number of contigous bases of determined sequence equals m−1.

### Claim 19 (depends on 18)

The method of claim 18, wherein the nucleic acid in the sample is mRNA.

### Claim 20 (depends on 18)

The method of claim 18 further comprising adding a polymerase to the sample.
